Altor Bioscience

Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
CP Wire
Fri, 04/6/18 - 12:00 am
metastatic non-small cell lung cancer
Altor Bioscience
ALT-803
Opdivo
Bristol-Myers Squibb
Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success
Thu, 04/5/18 - 11:40 pm
Opdivo
ALT-803
Bristol-Myers Squibb
Altor Bioscience